Case Report
Published on 14 Feb 2025
Ensartinib for EML4-ALK-positive lung adenocarcinoma with comorbid mutations in TP53, EGFR, and ERBB2: a case report
in Thoracic Oncology
- 1,588 views
Case Report
Published on 14 Feb 2025
in Thoracic Oncology
Original Research
Published on 13 Feb 2025
in Thoracic Oncology
Correction
Published on 12 Feb 2025
in Thoracic Oncology
Correction
Published on 12 Feb 2025
in Thoracic Oncology
Case Report
Published on 10 Feb 2025
in Thoracic Oncology
Case Report
Published on 10 Feb 2025
in Thoracic Oncology
Brief Research Report
Published on 06 Feb 2025
in Thoracic Oncology
Case Report
Published on 06 Feb 2025
in Thoracic Oncology
Case Report
Published on 03 Feb 2025
in Thoracic Oncology
Original Research
Published on 31 Jan 2025
in Thoracic Oncology
Original Research
Published on 30 Jan 2025
in Thoracic Oncology
Case Report
Published on 30 Jan 2025
in Thoracic Oncology
Original Research
Published on 30 Jan 2025
in Thoracic Oncology
Case Report
Published on 30 Jan 2025
in Thoracic Oncology
Case Report
Published on 30 Jan 2025
in Thoracic Oncology
Case Report
Published on 29 Jan 2025
in Thoracic Oncology